XmAb7195

· Xencor, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XmAb7195, covering 2017-01-24 to 2017-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195 [Phase 1]